Jean-come C. Meniane

Fort De France, 
Martinique, FR 
Fort De France, 
Martinique, FR 

Overview

Jean-come Meniane practices practicing medicine in Martinique, France.

Their clinical expertise encompasses Adult T-Cell Leukemia and Leukemia.

They are actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 2 clinical trials.

Locations

Fort De France, Martinique, France
Other Locations
Fort De France Bay, Bay, France
Montpellier, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Identification of Genetic Factors Predisposing to Dysglobulinemia
Identification of Genetic Factors Predisposing to Dysglobulinemia
Enrollment Status: Completed
Publish Date: September 03, 2025
Intervention Type: Genetic
Study Phase: Not Applicable
Observational Prospective Study, Evaluating the Standard of Care as Recommend by International Consensus With Zidovudine-Pegylated Interferon +/-Polychemotherapy in High Risk Adult-T-cell Lymphoma/Leukaemia (T-cell Lymphoma/Leukaemia) Followed by Allogeneic Transplant Among Eligible Patients Younger Than 65 Years Old
Observational Prospective Study, Evaluating the Standard of Care as Recommend by International Consensus With Zidovudine-Pegylated Interferon +/-Polychemotherapy in High Risk Adult-T-cell Lymphoma/Leukaemia (T-cell Lymphoma/Leukaemia) Followed by Allogeneic Transplant Among Eligible Patients Younger Than 65 Years Old
Enrollment Status: Completed
Publish Date: June 03, 2021
View 1 Less Clinical Trial

9 Total Publications

SWI/SNF alterations define a subgroup with poorer outcome among patients with aggressive forms of adult T-cell leukemia/lymphoma.
SWI/SNF alterations define a subgroup with poorer outcome among patients with aggressive forms of adult T-cell leukemia/lymphoma.
Journal: Haematologica
Published: February 13, 2026

Frequently Asked Questions about Jean-come C. Meniane

Is Jean-come C. Meniane a top-rated expert for Adult T-Cell Leukemia?

MediFind is an objective health platform that identifies experts based on real-world data. Jean-come C. Meniane is classified as an Experienced expert for Adult T-Cell Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jean-come C. Meniane participate in research or clinical trials?

Yes. Jean-come C. Meniane has published 9 articles and abstracts on conditions like Adult T-Cell Leukemia. You can view a list of Jean-come C. Meniane's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Meniane's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile